Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and
retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over
other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant
further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or
other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and
other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Audiobooks are now well over a billion - dollar business, and the available figures suggest that Amazon retains a
far larger piece of that revenue
than any
other retailer.
Most authors report that their books sell
far more copies on American book
retail sites
than on
other country sites.
iBooks charts, they have progressed much faster
than any
other retailer, as
far as what they've done and book sales and stuff like that.
And because of their size, they'll offer their Prime customers better shipping
than most
other retailers,
further setting Amazon apart as a super-seller.
My sales on
other retailers have always been
far,
far lower
than on Amazon.
For its own - label books, it takes from 30 to 65 percent of the list price of a book for itself —
far more profit
than the meager pennies it ekes out by being a
retailer for
other publishers.
But if you're going to use a distributor to reach Apple or Kobo (there's a host of
other retailers, but they're a tiny part of the market), I recommend using to Draft 2 Digital — D2D's converter isn't great, but it's
far better
than Smashword's «meatgrinder.»
In 2012 Seattle - based online
retailer's AmazonCrossing imprint published more works of fiction and poetry in translation
than any
other press except for Dalkey Archive, and is the largest publisher of literature in translation so
far this year, according to the most recent update of the «Translation Database» compiled by Open Letter Books Three Percent at the University of Rochester.
Look no
further than Kmart, one half of the sputtering
retail juggernaut that makes up Sears Holdings (Sears, of course, is the
other part of this fascinating
retail duo).
The same rule applies here: Cash - back cards are available with co-branding and perks from popular
retailers such as Costco and Amazon, but what you miss out on at
other stores is normally
far more
than what you gain.
So
far the port has bombed worse
than Wii U. Watch Dogs (Wii U) was delayed 6 months passed all the
other versions, it received no advertisement, and Ubisoft shipped very few copies to
retailers and then complained about bad sales.
Those games are
far more cheaper
than Amazon, ebay, gamestop or
other retailers.
Although there have been a few glimmers of hope in recent economic news, including an increase in mortgage applications, an increase in
retail sales, some positive cash flows and even profits by some of the larger banks, more clarity from the President about his stimulus package, and a rise in the stock market over the past week, so
far nothing has turned positive for the trucking industry, and
other than seasonal increases coming into the spring, likely won't for some time.
According to data from Chubb, the world's largest publicly traded property and casualty insurer, over the past decade the healthcare field has had
far more computer security incidents
than any
other industry, accounting for 38 % of incidents, versus 16 % for professional services, and 11 % for
retail.
Insolvent Target Canada's sale of its store leases and
other properties fetched
far less
than the amount the
retailer spent initially acquiring its leases — a reflection of the softening
retail real estate market in the wake of the U.S. discounter's exit from Canada.